BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, they are expediting development of their diverse pipeline o... Read more
View all
Seattle Genetics
Post IPO Equity • Bothell, United States
Karuna Therapeutics
Post IPO Equity • Boston, United States
Turning Point Therapeutics
Post IPO Equity • San Diego, United States
Veracyte
Post IPO Equity • South San Francisco, United States
Qunar Inc
Post IPO Equity • New York, United States
Sarepta Therapeutics
Post IPO Equity • Cambridge, United States
Standard BioTools
Post IPO Equity • South San Francisco, United States
REGENXBIO
Post IPO Equity • Rockville, United States
Sage Therapeutics
Post IPO Equity • Cambridge, United States
Kodiak
Post IPO Equity • Palo Alto, United States
Arrowhead Pharmaceuticals
Post IPO Equity • Pasadena, United States
Kura Oncology
Post IPO Equity • San Diego, United States